Stock to Watch!

Allezoe Medial, ALZM

Allezoe Medical has just launched a new subsidiary - SureScreen Medical - SureScreen will be responsible for taking HPV diagnostic technology through the appropriate trials and federal clearances.

HPV is linked to a number of cancers in both men and women, and it is the most common sexually transmitted infection and most people who become infected are completely unaware of it. Approximately 20 million Americans are infected with HPV — Experts believe that more than 5 million new infections occur each year.

Allezoe – ALZM – recently acquired a company that invented a breakthrough medical technology for the diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer

In addition Allezoe also has a subsidiary - Organ Transport Systems (OTS), a biomedical company developing and commercializing portable hypo-thermic, oxygenated preservation and transport technology for human organs.

The company is aggressively moving toward regulatory approval and commercialization of HPV treatment. It could be very lucrative because of its potential market size and relatively hassle free reimbursement from insurance companies.

The stock hit the bottom under heavy selling pressure and starting to bounce back. The recent acquisition and over sold conditions make it very attractive, short to medium term, very speculative and expect above average volatility.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Stock to Watch!

PPHM – Peregrine Pharmaceuticals

PPHM - Peregrine Pharmaceuticals is a biopharmaceutical company, engages in the research and development of monoclonal antibodies for the treatment of cancer and viral infections. Its products under development include bavituximab, which is in Phase II trials for the treatment of lung cancer and pancreatic cancer. The company is also developing ribavirin, which is in Phase II clinical trial for the treatment of patients with genotype-1 hepatitis C virus infections, liver cancer, prostate cancer and breast cancer.

Peregrine Pharma – PPHM - also provides contract manufacturing of antibodies, recombinant proteins, and enzymes; cell culture development; process development; and testing for biopharmaceutical and biotechnology companies. The company has licensing agreements with the University of Texas Southwestern Medical Center, Merck and SuperGen.

Great potential, Undervalued, Bouncing back from 52WK LOWS!

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks.

Stock to Watch!

Micro Vision, Mega Gains! (MVIS)

Micro Vision develops miniature laser display and imaging engines, The company's proprietary PicoP display engine technology uses two dimensional micro-electrical mechanical systems, lasers and optics to create a video or still image.

Micro Vision's products include Pico projector displays for portable hand-held devices, smart-phones, mobile phones and laptop computers.

MVIS also makes high resolution image displays, GPS mapping systems and audio controls used in cars today. In addition to consumer electronics Micro Vision products are used in medical and defense industries.

We think the stock at $0.35 cents is undervalued, oversold, could bounce back, it should be on your list.

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!®

we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks

Stock to Watch!

Del Toro Silver Corp. DTOR.OB

Del Toro Silver Corp. (DTOR.OB) is a dynamic mining company, primarily focused on historic gold mining districts in the state of California and the western USA. The company is targeting historical high grade gold properties that offer near term production potential at relatively low development and operating costs.

The Gold Rush

The Marshall discovery of gold at Sutter's Mill in 1848 started the California gold rush. When the news spread through the US the rush began. Americans from all over the country joined their compatriots from California and headed for the foothills of the Sierra Nevada.

Learn more about The Gold Rush

On November 14, 2011, Del Toro Silver Corp. (DTOR.OB) entered into an agreement for six of these historically producing gold mines by acquiring an option for the Discovery Day Gold Property. Past production records show that these six mines have produced at least 60,430 ozs of gold.

The Discovery Day mine was in production as recently as 2010. Mill Records from1996 show the mine produced 2,350 oz of gold, worth 4 million dollars. Learn more about the acquisition strategy

Key Points:

> The Discovery Day Gold Property is fully permitted for gold production by the authorities.

> Up to 75% of the project can be acquired by Del Toro.

> The Discovery Day mine located on the claims is a turnkey mine ready for production.

> Low production costs that are expected to run from $275 to $350 per ounce.

> The fully operational processing mill can produce up to 10,000 ounces of gold per year. Find out more compelling reasons

Laser focused

Del Toro is laser focused on historic mines in California and the western USA. Management's corporate strategy is the acquisition and development of mines that can be reworked and quickly put into production with relatively small initial capital expenditure.

OUTLOOK

Gold is likely to continue to trade at the $1,600 to $2,000 band in the near future. Consumer demand in third world countries is increasing, to combat Inflation, market volatility and currency fluctuations, Central Banks are increasing their gold reserves.

Read the full Summary, get to know the Management, learn more about their unique strategy. Click here

Don't miss the NEXT premium Alert! Sign-up, Get Alerts, MakeMoney!® we receive compensation from companies we feature. Always Read the full Disclosure/Disclaimer. Thanks